| Literature DB >> 27550341 |
Yuko Kato1, Shinya Suzuki2, Tokuhisa Uejima2, Hiroaki Semba2, Hiroto Kano2, Shunsuke Matsuno2, Hideaki Takai3, Takayuki Otsuka2, Yuji Oikawa2, Kazuyuki Nagashima2, Hajime Kirigaya2, Koichi Sagara2, Takashi Kunihara3, Junji Yajima2, Hitoshi Sawada2, Tadanori Aizawa2, Takeshi Yamashita2.
Abstract
This study aimed to examine the discrete impacts of peak oxygen consumption (VO2) and brain natriuretic peptide (BNP) levels on future heart failure (HF) events in sinus rhythm (SR) and atrial fibrillation (AF). A total of 1447 patients who underwent symptom-limited cardiopulmonary exercise testing and whose BNP values were determined simultaneously were analysed (SR, N = 1151 and AF, N = 296). HF events were defined as HF hospitalization or HF death. Over a mean follow-up period of 1472 days, 140 HF events were observed. A high BNP value (dichotomized by median value) was independently associated with HF events in SR (HR 8.08; 95 % CI 4.02-16.26; p < 0.0001), but not in AF patients (HR 1.97; 95 % CI 0.91-4.28; p = 0.087) with a significant interaction between the rhythms. By contrast, low-peak VO2 was independently associated with HF events in both rhythms (AF; HR 5.81; 95 % CI 1.75-19.30; p = 0.004, SR; HR 2.04; 95 % CI 1.19-3.49; p = 0.009), with a marginal interaction between them. In bivariate Cox models, low-peak VO2 had much stronger predictive power for HF events than high-BNP in AF, whereas high-BNP was more powerful than low-peak VO2 in SR. The prognostic value of BNP and peak VO2 for future HF events seemed to be different between SR and AF.Entities:
Keywords: Atrial fibrillation; Brain natriuretic peptide; Peak VO2; Sinus rhythm
Mesh:
Substances:
Year: 2016 PMID: 27550341 DOI: 10.1007/s00380-016-0887-x
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 2.037